These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17433862)

  • 1. Linking the elements of change: Program and client responses to innovation.
    Simpson DD; Joe GW; Rowan-Szal GA
    J Subst Abuse Treat; 2007 Sep; 33(2):201-9. PubMed ID: 17433862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of organizational functioning on client engagement in treatment.
    Greener JM; Joe GW; Simpson DD; Rowan-Szal GA; Lehman WE
    J Subst Abuse Treat; 2007 Sep; 33(2):139-47. PubMed ID: 17433863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of the relationship between staff perceptions of organizational readiness to change and the process of innovation adoption in substance misuse treatment programs.
    Kelly P; Hegarty J; Barry J; Dyer KR; Horgan A
    J Subst Abuse Treat; 2017 Sep; 80():6-25. PubMed ID: 28755775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counselor perceptions of organizational factors and innovations training experiences.
    Joe GW; Broome KM; Simpson DD; Rowan-Szal GA
    J Subst Abuse Treat; 2007 Sep; 33(2):171-82. PubMed ID: 17434706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using organizational assessment as a tool for program change.
    Courtney KO; Joe GW; Rowan-Szal GA; Simpson DD
    J Subst Abuse Treat; 2007 Sep; 33(2):131-7. PubMed ID: 17433861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving innovations into treatment: A stage-based approach to program change.
    Simpson DD; Flynn PM
    J Subst Abuse Treat; 2007 Sep; 33(2):111-20. PubMed ID: 17434704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counselor assessments of training and adoption barriers.
    Bartholomew NG; Joe GW; Rowan-Szal GA; Simpson DD
    J Subst Abuse Treat; 2007 Sep; 33(2):193-9. PubMed ID: 17434707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Organizational Readiness for Change scale in adolescent programs: Criterion validity.
    Saldana L; Chapman JE; Henggeler SW; Rowland MD
    J Subst Abuse Treat; 2007 Sep; 33(2):159-69. PubMed ID: 17434703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relating counselor attributes to client engagement in England.
    Simpson D; Rowan-Szal GA; Joe GW; Best D; Day E; Campbell A
    J Subst Abuse Treat; 2009 Apr; 36(3):313-20. PubMed ID: 18835675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organizational Readiness for Change and opinions toward treatment innovations.
    Fuller BE; Rieckmann T; Nunes EV; Miller M; Arfken C; Edmundson E; McCarty D
    J Subst Abuse Treat; 2007 Sep; 33(2):183-92. PubMed ID: 17434708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using peer, self, and counselor ratings to evaluate treatment progress.
    Czuchry M; Dansereau DF; Sia TL; Simpson DD
    J Psychoactive Drugs; 1998; 30(1):81-7. PubMed ID: 9565211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal perspective on monitoring outcomes of an innovative program.
    Rosenheck RA; Seibyl CL
    Psychiatr Serv; 2005 Mar; 56(3):301-7. PubMed ID: 15746504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A structural model of treatment program and individual counselor leadership in innovation transfer.
    Joe GW; Becan JE; Knight DK; Flynn PM
    BMC Health Serv Res; 2017 Mar; 17(1):230. PubMed ID: 28335765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of treatment innovation planning and implementation: strategic process models and organizational challenges.
    Lehman WE; Simpson DD; Knight DK; Flynn PM
    Psychol Addict Behav; 2011 Jun; 25(2):252-61. PubMed ID: 21443294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of drug counselor training: a pilot study.
    Tierney DO; Mauer J; Williams CE; Howard LM; Bianco DM
    Int J Addict; 1983 May; 18(4):511-21. PubMed ID: 6629560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing program needs and planning change.
    Rowan-Szal GA; Greener JM; Joe GW; Simpson DD
    J Subst Abuse Treat; 2007 Sep; 33(2):121-9. PubMed ID: 17434705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovation attributes and adoption decisions: perspectives from leaders of a national sample of addiction treatment organizations.
    Knudsen HK; Roman PM
    J Subst Abuse Treat; 2015 Feb; 49():1-7. PubMed ID: 25218918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Program structure, staff perceptions, and client engagement in treatment.
    Broome KM; Flynn PM; Knight DK; Simpson DD
    J Subst Abuse Treat; 2007 Sep; 33(2):149-58. PubMed ID: 17434709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.